Literature DB >> 6406534

Follicle-stimulating hormone induced ovarian hyperstimulation in monkeys: blockade of the luteinizing hormone surge.

R S Schenken, G D Hodgen.   

Abstract

The availability of a pure human FSH preparation for studies of the primate ovarian/menstrual cycle permitted novel experiments on gonadotropic stimulation of follicular growth in monkeys. Administration of pure FSH on days 1 through 12 of the menstrual cycle resulted in significant ovarian hyperstimulation, as manifested by the development of multiple (bilateral) ovarian follicles and sustained high serum estradiol levels (approximately 400 pg/ml). In spite of overt follicular development and concurrent increases in serum estradiol, timely LH surges were not elicited. Similarly, during FSH-induced ovarian hyperstimulation, GnRH effects on LH secretion were blunted. Equivalent FSH treatments of long term ovariectomized monkeys had no discernible effects on estrogen-induced LH surges or GnRH responses. Our interpretation is that when supraphysiological FSH levels persist into the late follicular phase, thereby overriding selection of the single dominant follicle of the natural cycle, secretion of an ovarian factor(s) blocks estrogen-induced LH surges.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406534     DOI: 10.1210/jcem-57-1-50

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

Review 2.  Drugs used in in vitro fertilisation procedures.

Authors:  I E Messinis
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 3.  Gonadotropin surge-inhibiting/attenuating factors: a review of current evidence, potential applications, and future directions for research.

Authors:  Mario G Vega; Shvetha M Zarek; Medha Bhagwat; James H Segars
Journal:  Mol Reprod Dev       Date:  2015-01-12       Impact factor: 2.609

4.  Clinical aspects with regard to the occurrence of an endogenous luteinizing hormone surge in gonadotropin-induced normal menstrual cycles.

Authors:  J F Van Uem; J E Garcia; H C Liu; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1986-12

5.  The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.

Authors:  D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

6.  Endogenous luteinizing hormone release using human menopausal gonadotropins for in vitro fertilization.

Authors:  J M Vargyas; R P Marrs
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-04

7.  Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).

Authors:  T Kagawa; S Yamano; S Nishida; S Murayama; T Aono
Journal:  J Assist Reprod Genet       Date:  1992-04       Impact factor: 3.412

8.  Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.

Authors:  D Kreiner; K Droesch; J Itskovitz; H C Liu; D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.